# Integrative Sequencing In Germline and Hereditary Tumours

> **NCT03857594** · — · ACTIVE_NOT_RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 10 (estimated)

## Conditions studied

- Hereditary Cancer Syndrome
- High-Risk
- Mutation
- Germline Mutation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03857594
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-10-02
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03857594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03857594, "Integrative Sequencing In Germline and Hereditary Tumours". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03857594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*